osimertinib
astrazeneca
['osimertinib']
when discussing adjuvant osimertinib- can t downplay chronic toxicity of long term targeted therapy. dr. credits for highlighting this critical aspect of cancer care - with rousing applause from the #asco23 audience. 
Director of Thoracic Oncology & Developmental Therapeutics @LombardiCancer, Associate Professor @Georgetown, Co-Host Official @IASLC Podcast, #ITYSL, #HereWeGo